Corrigendum: Interleukin-13 as a potential biomarker in the management of pediatric asthma – a longitudinal study

dc.contributor.authorRaju, Prasanna
dc.contributor.authorSundar, Subash
dc.contributor.authorSuresh, Preethi
dc.contributor.authorVajravelu, Leela Kakithakara
dc.contributor.authorAravindhan, Vivekanandhan
dc.date.accessioned2025-06-28T19:54:16Z
dc.date.available2025-06-28T19:54:16Z
dc.date.issued2025-06
dc.description.abstractA Corrigendum on Interleukin-13 as a potential biomarker in the management of pediatric asthma – a longitudinal study by Raju P, Sundar S, Suresh P, Vajravelu LK, Aravindhan V. Eur J Clin Exp Med. 2025;23(1):15–20. doi: 10.15584/ejcem.2025.1.3.
dc.identifier.citationEuropean Journal of Clinical and Experimental Medicine T. 23, z. 2 (2025), s. 531
dc.identifier.doi10.15584/ejcem.2025.2.29
dc.identifier.issn2544-1361
dc.identifier.urihttps://repozytorium.ur.edu.pl/handle/item/11599
dc.language.isoeng
dc.publisherRzeszów University Press
dc.rightsAttribution-NonCommercial-NoDerivatives 4.0 Internationalen
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/
dc.titleCorrigendum: Interleukin-13 as a potential biomarker in the management of pediatric asthma – a longitudinal study
dc.typearticle

Pliki

Oryginalny pakiet

Aktualnie wyświetlane 1 - 1 z 1
Ładowanie...
Obrazek miniatury
Nazwa:
EJCEM_29_2_2025.pdf
Rozmiar:
57.08 KB
Format:
Adobe Portable Document Format

Pakiet licencji

Aktualnie wyświetlane 1 - 1 z 1
Nazwa:
license.txt
Rozmiar:
1.28 KB
Format:
Item-specific license agreed upon to submission
Opis: